Company Financials: Orthopaedic and Spine

• Posted in Business Critical | October 11, 2011 | Comments (0)
• Tags: supplier, vetalice, earnings, spine, financial, market growth, sales, oem, market, earning
• By: Julie A. Vetalice

ORTHOWORLD estimates place 2Q11 market growth at 5% over 2Q10 as shown in Exhibit 1, which displays 2Q orthopaedic sales growth by product segment for select companies. Performance highlights follow.

Exhibit 1: Orthopaedic Sales¹ Increases by Product Segment: 2Q11 vs. 2Q10 

Notes to Exhibit 1

¹ Orthopaedic products only; constant currency, pro forma growth
² Includes biologics
³ For the quarter ended 5/31/11; trauma includes stimulators; spine includes stimulators and orthobiologics.
⁴ For the quarter ended 7/29/11
⁵ Spine
⁶ For the quarter ended 6/30/11
⁷ Extremities: extremities + fixation combined; Endoscopy: endoscopic + communications, most of which is orthopaedic; Spine: neuro + spine. Total growth excludes Patient handling.
⁸ ORTHOWORLD estimates
⁹ For the quarter ended 6/30/11
¹⁰ Excludes "Other" (Aerospace)